• Publications
  • Influence
Cellulosic ethanol fights for life
Pioneering biofuel producers hope that US government largesse will ease their way into a tough market.
The 100 000 Genomes Project
  • M. Peplow
  • Biology
    British Medical Journal
  • 13 April 2016
TLDR
This enormous sequencing programme could usher genomic medicine into mainstream use, Mark Peplow reports.
Synthetic biology’s first malaria drug meets market resistance
TLDR
Yet Sanofi produced no ‘semi-synthetic’ artemisinin (SSA) at all in 2015, and the company is now selling the manufacturing site in Garessio, Italy, where it made its SSA.
Organic synthesis: The robo-chemist
TLDR
The race is on to build a machine that can synthesize any organic compound, because the essence of what researchers are doing is the same, and it could transform chemistry.
The plastics revolution: how chemists are pushing polymers to new limits
TLDR
Next-generation polymers have infiltrated almost every aspect of modern life and researchers are working on next-generation forms that will help in the development of sustainable materials.
How fracking is upending the chemical industry
  • M. Peplow
  • Materials Science, Medicine
    Nature
  • 5 October 2017
Nerve agent attack used ‘Novichok’ poison
TLDR
The nerve agent used in the attempted murder of a former Russian double agent living in the U.K. is part of a family of compounds known as Novichok agents developed in a Cold War-era weapons program in the former U.S.R.
Special Report: Counting the dead
  • M. Peplow
  • Environmental Science
    Nature
  • 1 April 2006
TLDR
This week's cover shows a helicopter crew monitoring radioactivity above the damaged reactor 4 later that summer, and in a series of pieces in this issue the authors chart the costs of Chernobyl, the world's worst peacetime nuclear accident, in terms of human lives and ecological damage.
Social sciences suffer from severe publication bias
Survey finds that ‘null results’ rarely see the light of the day.
...
...